Cost-effectiveness of preimmunization hepatitis B screening in high-risk adolescents

Public Health Reports

Volumn 116, Issue 2, 2001, Pages 165-168

  Blostein, Joel ^a   Clark, Patricia A ^a  

^a MICHIGAN DEPARTMENT OF COMMUNITY HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B CORE ANTIBODY; HEPATITIS VACCINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANTIBODY TITER; ARTICLE; CALCULATION; CHILD; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; HEPATITIS B; HIGH RISK POPULATION; HUMAN; IMMUNIZATION; INFANT; MAJOR CLINICAL STUDY; MASS SCREENING; NEWBORN; PRIORITY JOURNAL; SEROPREVALENCE;

EID: 0035678207     PISSN: 00333549     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0033-3549(04)50008-0     Document Type: Article

References (6)

1. Immunization of adolescents: Recommendations of the Advisory Committee on Immunization Practices, the American Academy of Pediatrics, the American Academy of Family Physicians, and the American Medical Association
2. Protection against viral hepatitis: Recommendations of the Advisory Committee on Immunization Practices
3. Prevalence of hepatitis B virus infection in the United States: The National Health and Nutrition Examination Surveys, 1976 through 1994
4. Is prevaccination screening for hepatitis B among sexually active adolescents cost-effective?